Report Detail
Global Embolization Particle Market Growth 2019-2024
- RnM2847758 |
- 31 January, 2019 |
- Global |
- 135 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Embolization Particle or embolisation refers to the passage and lodging of an embolus within the bloodstream. It may be pathological (in which sense it is also called embolism), for example a pulmonary embolism, or therapeutic, as a hemostatic treatment for bleeding or as a treatment for some types of cancer by deliberately blocking blood vessels to starve the tumor cells.
USA has the largest global export quantity and manufacturers in Embolization Particle market, while the Europe is the second sales volume market for Embolization Particle in 2016.
In the industry, Sirtex Medical profits most in 2016 and recent years, while Merit Medical and BTG Medical ranked 2 and 3.The market share of them is 23.11%, 17.44% and 14.53% in 2016.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are four mainly types of Embolization Particle, including Microspheres, Particles, DEBs and Radio-Embolic Microspheres. And Microspheres is the main type for Embolization Particle, and the Microspheres reached a sales value of approximately 347.54 M USD in 2016, with 34.55% of global sales volume.
According to this study, over the next five years the Embolization Particle market will register a 14.4% CAGR in terms of revenue, the global market size will reach US$ 2610 million by 2024, from US$ 1170 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Embolization Particle business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Embolization Particle market by product type, application, key manufacturers and key regions and countries.
This study considers the Embolization Particle value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Microspheres
Particles (e.g. PVA Particles, Gelfoam Particles)
Drug-eluting Beads (DEBs)
Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Uterine Fibroid Embolization
Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
Liver Tumor Embolization
Trauma Embolization
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sirtex Medical
Merit Medical
Cook Medical
BTG Medical
Boston Scientific Corporation
Terumo Corporation
HENGRUI Medical
INterface BIOmaterials B.V.
Alicon
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Embolization Particle consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Embolization Particle market by identifying its various subsegments.
Focuses on the key global Embolization Particle manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Embolization Particle with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Embolization Particle submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Embolization Particle Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Embolization Particle Consumption 2014-2024
- 2.1.2 Embolization Particle Consumption CAGR by Region
- 2.2 Embolization Particle Segment by Type
- 2.2.1 Microspheres
- 2.2.2 Particles (e.g. PVA Particles, Gelfoam Particles)
- 2.2.3 Drug-eluting Beads (DEBs)
- 2.2.4 Radio-Embolic Microspheres (e.g. Therasphere and SIRSphere)
- 2.3 Embolization Particle Consumption by Type
- 2.3.1 Global Embolization Particle Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Embolization Particle Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Embolization Particle Sale Price by Type (2014-2019)
- 2.4 Embolization Particle Segment by Application
- 2.4.1 Uterine Fibroid Embolization
- 2.4.2 Prostatic Artery Embolization (treatment for Benign Prostatic Hyperplasia or BPH)
- 2.4.3 Liver Tumor Embolization
- 2.4.4 Trauma Embolization
- 2.4.5 Other
- 2.5 Embolization Particle Consumption by Application
- 2.5.1 Global Embolization Particle Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Embolization Particle Value and Market Share by Application (2014-2019)
- 2.5.3 Global Embolization Particle Sale Price by Application (2014-2019)
3 Global Embolization Particle by Players
- 3.1 Global Embolization Particle Sales Market Share by Players
- 3.1.1 Global Embolization Particle Sales by Players (2017-2019)
- 3.1.2 Global Embolization Particle Sales Market Share by Players (2017-2019)
- 3.2 Global Embolization Particle Revenue Market Share by Players
- 3.2.1 Global Embolization Particle Revenue by Players (2017-2019)
- 3.2.2 Global Embolization Particle Revenue Market Share by Players (2017-2019)
- 3.3 Global Embolization Particle Sale Price by Players
- 3.4 Global Embolization Particle Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Embolization Particle Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Embolization Particle Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Embolization Particle by Regions
- 4.1 Embolization Particle by Regions
- 4.1.1 Global Embolization Particle Consumption by Regions
- 4.1.2 Global Embolization Particle Value by Regions
- 4.2 Americas Embolization Particle Consumption Growth
- 4.3 APAC Embolization Particle Consumption Growth
- 4.4 Europe Embolization Particle Consumption Growth
- 4.5 Middle East & Africa Embolization Particle Consumption Growth
5 Americas
- 5.1 Americas Embolization Particle Consumption by Countries
- 5.1.1 Americas Embolization Particle Consumption by Countries (2014-2019)
- 5.1.2 Americas Embolization Particle Value by Countries (2014-2019)
- 5.2 Americas Embolization Particle Consumption by Type
- 5.3 Americas Embolization Particle Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Embolization Particle Consumption by Countries
- 6.1.1 APAC Embolization Particle Consumption by Countries (2014-2019)
- 6.1.2 APAC Embolization Particle Value by Countries (2014-2019)
- 6.2 APAC Embolization Particle Consumption by Type
- 6.3 APAC Embolization Particle Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Embolization Particle by Countries
- 7.1.1 Europe Embolization Particle Consumption by Countries (2014-2019)
- 7.1.2 Europe Embolization Particle Value by Countries (2014-2019)
- 7.2 Europe Embolization Particle Consumption by Type
- 7.3 Europe Embolization Particle Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Embolization Particle by Countries
- 8.1.1 Middle East & Africa Embolization Particle Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Embolization Particle Value by Countries (2014-2019)
- 8.2 Middle East & Africa Embolization Particle Consumption by Type
- 8.3 Middle East & Africa Embolization Particle Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Embolization Particle Distributors
- 10.3 Embolization Particle Customer
11 Global Embolization Particle Market Forecast
- 11.1 Global Embolization Particle Consumption Forecast (2019-2024)
- 11.2 Global Embolization Particle Forecast by Regions
- 11.2.1 Global Embolization Particle Forecast by Regions (2019-2024)
- 11.2.2 Global Embolization Particle Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Embolization Particle Forecast by Type
- 11.8 Global Embolization Particle Forecast by Application
12 Key Players Analysis
- 12.1 Sirtex Medical
- 12.1.1 Company Details
- 12.1.2 Embolization Particle Product Offered
- 12.1.3 Sirtex Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Sirtex Medical News
- 12.2 Merit Medical
- 12.2.1 Company Details
- 12.2.2 Embolization Particle Product Offered
- 12.2.3 Merit Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merit Medical News
- 12.3 Cook Medical
- 12.3.1 Company Details
- 12.3.2 Embolization Particle Product Offered
- 12.3.3 Cook Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Cook Medical News
- 12.4 BTG Medical
- 12.4.1 Company Details
- 12.4.2 Embolization Particle Product Offered
- 12.4.3 BTG Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 BTG Medical News
- 12.5 Boston Scientific Corporation
- 12.5.1 Company Details
- 12.5.2 Embolization Particle Product Offered
- 12.5.3 Boston Scientific Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Boston Scientific Corporation News
- 12.6 Terumo Corporation
- 12.6.1 Company Details
- 12.6.2 Embolization Particle Product Offered
- 12.6.3 Terumo Corporation Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Terumo Corporation News
- 12.7 HENGRUI Medical
- 12.7.1 Company Details
- 12.7.2 Embolization Particle Product Offered
- 12.7.3 HENGRUI Medical Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 HENGRUI Medical News
- 12.8 INterface BIOmaterials B.V.
- 12.8.1 Company Details
- 12.8.2 Embolization Particle Product Offered
- 12.8.3 INterface BIOmaterials B.V. Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 INterface BIOmaterials B.V. News
- 12.9 Alicon
- 12.9.1 Company Details
- 12.9.2 Embolization Particle Product Offered
- 12.9.3 Alicon Embolization Particle Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Alicon News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Embolization Particle . Industry analysis & Market Report on Embolization Particle is a syndicated market report, published as Global Embolization Particle Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Embolization Particle market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
